These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 11130333
1. Correlation of flow cytometric parameters and transferrin receptors with gallium-67 scintigraphic images in lymphoma patients. Kiratli PO, Canpinar H, Ruacan S, Kansu E. Nucl Med Commun; 2000 Oct; 21(10):925-31. PubMed ID: 11130333 [Abstract] [Full Text] [Related]
2. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma. Wirth A, Seymour JF, Hicks RJ, Ware R, Fisher R, Prince M, MacManus MP, Ryan G, Januszewicz H, Wolf M. Am J Med; 2002 Mar; 112(4):262-8. PubMed ID: 11893364 [Abstract] [Full Text] [Related]
3. CD71 phenotype and the value of gallium imaging in lymphomas. Feremans W, Bujan W, Neve P, Delville JP, Schandene L. Am J Hematol; 1991 Mar; 36(3):215-6. PubMed ID: 1996560 [Abstract] [Full Text] [Related]
4. Three cases demonstrating the role of gallium scanning in relapsing Hodgkin's disease and non-Hodgkin lymphoma. Zollars LE, Nagel JS, Tumeh SS. J Nucl Med; 1987 Oct; 28(10):1611-5. PubMed ID: 3655913 [Abstract] [Full Text] [Related]
5. 67Ga scintigraphy in B-cell non-Hodgkin's lymphoma: correlation of 67Ga uptake with histology and transferrin receptor expression. Nejmeddine F, Raphael M, Martin A, Le Roux G, Moretti JL, Caillat-Vigneron N. J Nucl Med; 1999 Jan; 40(1):40-5. PubMed ID: 9935054 [Abstract] [Full Text] [Related]
6. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma. Shen YY, Kao A, Yen RF. Oncol Rep; 2002 Jan; 9(2):321-5. PubMed ID: 11836600 [Abstract] [Full Text] [Related]
7. Gallium-67 scintigraphy in the management: Hodgkin's disease and non-Hodgkin's lymphoma. Rehm PK. Cancer Biother Radiopharm; 1999 Aug; 14(4):251-62. PubMed ID: 10850311 [Abstract] [Full Text] [Related]
8. [False-positive findings of 67-gallium scintigraphy in staging/restaging of malignant lymphoma]. Bihl H, Kimmig B. Rofo; 1987 Feb; 146(2):172-7. PubMed ID: 3029830 [Abstract] [Full Text] [Related]
9. Revisiting the prognostic role of gallium scintigraphy in low-grade non-Hodgkin's lymphoma. Gallamini A, Biggi A, Fruttero A, Pugno F, Cavallero G, Pregno P, Grasso M, Farinelli C, Leone A, Gallo E. Eur J Nucl Med; 1997 Dec; 24(12):1499-506. PubMed ID: 9391185 [Abstract] [Full Text] [Related]
10. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma. Yang CC, Sun SS, Lin CC, Kao CH, Lee CC. Anticancer Res; 2001 Dec; 21(5):3695-8. PubMed ID: 11848545 [Abstract] [Full Text] [Related]
11. Visualization of esophageal non-Hodgkin's lymphoma with Ga-67 scintigraphy. Nishryama Y, Yamamoto Y, Ono Y, Satoh K, Ohkawa M, Yamauchi A, Tanabe M. Ann Nucl Med; 1999 Dec; 13(6):419-21. PubMed ID: 10656277 [Abstract] [Full Text] [Related]
12. Comparison of gallium-67-citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma. Waxman AD, Eller D, Ashook G, Ramanna L, Brachman M, Heifetz L, McAndrews P, Bierman H, Taub R, Avedo M, Wall F. J Nucl Med; 1996 Jan; 37(1):46-50. PubMed ID: 8544000 [Abstract] [Full Text] [Related]
13. The role of high dose 67-gallium scintigraphy in staging untreated patients with lymphoma. Larcos G, Farlow DC, Antico VF, Gruenewald SM, Boyages J. Aust N Z J Med; 1994 Feb; 24(1):5-8. PubMed ID: 8002858 [Abstract] [Full Text] [Related]
14. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma. Zinzani PL, Zompatori M, Bendandi M, Battista G, Fanti S, Barbieri E, Gherlinzoni F, Rimondi MR, Frezza G, Pisi P, Merla E, Gozzetti A, Canini R, Monetti N, Babini L, Tura S. Leuk Lymphoma; 1996 Jun; 22(1-2):131-5. PubMed ID: 8724540 [Abstract] [Full Text] [Related]
15. High-dose gallium imaging in lymphoma. Anderson KC, Leonard RC, Canellos GP, Skarin AT, Kaplan WD. Am J Med; 1983 Aug; 75(2):327-31. PubMed ID: 6881185 [Abstract] [Full Text] [Related]
16. The use of gallium-67 scintigraphy to monitor tumor response rates and predict long-term clinical outcome in patients with lymphoma. Tuli MM, Al-Shemmari SH, Ameen RM, Al-Muhanadi S, Al-Huda FA, Ballani N, Khoshi M, Al-Enezi F, Bajciova V, Mottl H. Clin Lymphoma; 2004 Jun; 5(1):56-61. PubMed ID: 15245609 [Abstract] [Full Text] [Related]
17. [Gallium-67 scintigraphy in malignant lymphoma]. Cohen-Haguenauer O, Brice P, Gaci M, Le Pailleur A, Cheval E, Bris C, Frija J, Gisselbrecht C, Rain JD, Najean Y. Presse Med; 1993 Mar 27; 22(11):521-5. PubMed ID: 8511078 [Abstract] [Full Text] [Related]
18. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value. Castellani MR, Cefalo G, Terenziani M, Aliberti G, Maccauro M, Alessi A, Villano C, Bombardieri E. Q J Nucl Med; 2003 Mar 27; 47(1):22-30. PubMed ID: 12714951 [Abstract] [Full Text] [Related]
19. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy. Delcambre C, Reman O, Henry-Amar M, Peny AM, Macro M, Cheze S, Génot JY, Tanguy A, Switsers O, Van HL, Couëtte JE, Leporrier M, Bardet S. Eur J Nucl Med; 2000 Feb 27; 27(2):176-84. PubMed ID: 10755723 [Abstract] [Full Text] [Related]
20. 18FDG PET versus high-dose 67Ga scintigraphy for restaging and treatment follow-up of lymphoma patients. Van Den Bossche B, Lambert B, De Winter F, Kolindou A, Dierckx RA, Noens L, Van De Wiele C. Nucl Med Commun; 2002 Nov 27; 23(11):1079-83. PubMed ID: 12411836 [Abstract] [Full Text] [Related] Page: [Next] [New Search]